BIDU-SW
09888
BOSS ZHIPIN-W
02076
JD-SW
09618
NTES-S
09999
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q9)Sep 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 5.65%413.11M | -6.11%867.76M | -23.40%391.03M | -22.86%924.2M | -3.06%510.47M | 16.48%1.2B | --526.57M | 47.02%1.03B | 52.09%807.66M | 82.79%699.59M |
Operating income | 5.65%413.11M | -6.11%867.76M | -23.40%391.03M | -22.86%924.2M | -3.06%510.47M | 16.48%1.2B | 526.57M | 47.02%1.03B | 52.09%807.66M | 82.79%699.59M |
Cost of sales | 21.65%-120.22M | -128.01%-341.25M | -77.52%-153.44M | 44.72%-149.67M | 27.78%-86.44M | 32.00%-270.76M | ---119.69M | -18.28%-398.16M | -34.87%-333.35M | -77.91%-336.62M |
Operating expenses | 21.65%-120.22M | -128.01%-341.25M | -77.52%-153.44M | 44.72%-149.67M | 27.78%-86.44M | 32.00%-270.76M | -119.69M | -18.28%-398.16M | -34.87%-333.35M | -77.91%-336.62M |
Gross profit | 23.27%292.89M | -32.02%526.52M | -43.97%237.59M | -16.47%774.54M | 4.21%424.03M | 47.09%927.25M | 406.88M | 73.67%630.38M | 67.07%474.32M | 87.56%362.97M |
Selling expenses | -13.38%-66.16M | 15.22%-137.84M | 19.13%-58.35M | -19.32%-162.58M | -24.49%-72.15M | -58.05%-136.25M | ---57.96M | -26.51%-86.21M | -33.08%-60.67M | -59.25%-68.14M |
Administrative expenses | -8.81%-113.73M | 11.82%-207.74M | 6.95%-104.52M | -7.01%-235.58M | -12.31%-112.33M | -100.12%-220.15M | ---100.01M | -33.20%-110.01M | -31.02%-75.22M | -35.77%-82.59M |
Research and development expenses | 5.97%-177.67M | -4.18%-365.8M | -17.98%-188.95M | -26.57%-351.12M | -33.33%-160.15M | -167.45%-277.41M | ---120.11M | -73.23%-103.73M | -71.67%-79.17M | -45.00%-59.88M |
Impairment and provision | -127.16%-162.38M | -412.73%-214.44M | -215.27%-71.48M | 20.55%-41.82M | -33.75%-22.67M | -22.36%-52.64M | ---16.95M | -59.02%-43.02M | -142.30%-33.31M | -682.61%-27.06M |
-Other impairment is provision | -127.16%-162.38M | -412.73%-214.44M | -215.27%-71.48M | 20.55%-41.82M | -33.75%-22.67M | -22.36%-52.64M | ---16.95M | -59.02%-43.02M | -142.30%-33.31M | -682.61%-27.06M |
Special items of operating profit | -2.04%40.5M | -53.28%58.72M | 21.31%41.34M | 62.78%125.68M | -25.73%34.08M | 134.28%77.21M | --45.89M | 125.73%32.96M | 183.80%24.72M | 53.39%14.6M |
Operating profit | -29.21%-186.54M | -412.13%-340.58M | -258.97%-144.37M | -65.69%109.12M | -42.43%90.81M | -0.74%318.01M | 157.74M | 128.98%320.37M | 93.20%250.67M | 155.88%139.91M |
Financing cost | -91.19%-7.12M | 72.57%-8.31M | 79.43%-3.73M | 77.59%-30.28M | 76.01%-18.11M | 3.75%-135.14M | ---75.5M | -29.65%-140.41M | -24.71%-120.47M | -44.06%-108.3M |
Share of profits of associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 617.07%8.18M | -48,809.09%-5.36M |
Special items of earning before tax | 42.90%-22.19M | -23.17%-75M | -100.18%-38.85M | 99.54%-60.89M | 99.85%-19.41M | -1,433.01%-13.1B | ---13.08B | 22.89%-854.41M | -33.78%-534.56M | 20.64%-1.11B |
Earning before tax | -15.46%-215.85M | -2,462.51%-423.88M | -450.77%-186.95M | 100.14%17.94M | 100.41%53.3M | -1,814.96%-12.92B | -13B | 37.66%-674.44M | -7.65%-396.18M | 23.64%-1.08B |
Tax | -267.89%-25.67M | 51.21%-19.42M | 184.48%15.29M | 47.22%-39.8M | 50.28%-18.1M | -83.72%-75.4M | ---36.41M | -25,391.93%-41.04M | -2,378.55%-35.82M | -102.53%-161K |
After-tax profit from continuing operations | -40.70%-241.52M | -1,928.36%-443.3M | -587.73%-171.66M | 99.83%-21.86M | 100.27%35.2M | -1,715.65%-12.99B | -13.03B | 33.87%-715.48M | -16.92%-431.99M | 23.28%-1.08B |
Earning after tax | -40.70%-241.52M | -1,928.36%-443.3M | -587.73%-171.66M | 99.83%-21.86M | 100.27%35.2M | -1,715.65%-12.99B | -13.03B | 33.87%-715.48M | -16.92%-431.99M | 23.28%-1.08B |
Minority profit | 46.87%-721K | 75.49%-2.06M | 82.72%-1.36M | -851.75%-8.4M | -2,216.17%-7.85M | -29.03%1.12M | --371K | 568.45%1.57M | 36,533.33%1.1M | ---336K |
Profit attributable to shareholders | -41.40%-240.8M | -3,178.64%-441.24M | -495.62%-170.3M | 99.90%-13.46M | 100.33%43.05M | -1,711.82%-12.99B | -13.03B | 33.71%-717.06M | -17.22%-433.09M | 23.30%-1.08B |
Basic earnings per share | -37.50%-0.11 | -3,366.67%-0.208 | -500.00%-0.08 | 99.92%-0.006 | 100.18%0.02 | 66.51%-7.784 | -11.06 | 33.71%-23.24 | -17.20%-14.04 | 23.30%-35.06 |
Diluted earnings per share | -37.50%-0.11 | -3,366.67%-0.208 | -500.00%-0.08 | 99.92%-0.006 | 100.18%0.02 | 66.51%-7.784 | -11.06 | 33.71%-23.24 | -17.20%-14.04 | 23.30%-35.06 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.